# Developmental Research Program

> **NIH NIH P50** · MAYO CLINIC ROCHESTER · 2022 · $57,323

## Abstract

DEVELOPMENTAL RESEARCH PROGRAM – PROJECT SUMMARY 
 The goal of the Mayo Clinic HBCs SPORE Developmental Research Program (DRP) is to attract, develop, 
support, and monitor the most promising and innovative projects pertaining to translational hepatobiliary cancer 
research. Each year the DRP will provide three, one-year awards of $50,000 each with the possibility of an 
additional year of support based upon the demonstration of significant progress and potential. A rigorous peer- 
review process utilizing the expertise of the Internal Scientific Advisory Committee and other experienced 
investigators will evaluate all applications based upon the following criteria: scientific merit, originality, 
qualifications of the applicant/co-investigator(s), and translational potential. While the translational trajectory of 
all applications needs to be readily apparent, we encourage high risk/high payoff proposals investigating all 
aspects pertaining to the morbidity and mortality of hepatobiliary cancer from the bench to the population. This 
will be accomplished through the following Specific Aims: (1) Solicit and support innovative and 
interdisciplinary translationally-relevant laboratory, population science, and clinical studies in hepatobiliary 
cancer; (2) Encourage the recruitment of qualified minorities, women, and persons with disabilities; (3) Provide 
critical evaluation of all DRP applications and awardee progress; and (4) Facilitate the development of DRP 
funded proposals into R01-level applications and/or future HBCs SPORE projects. It is expected that 
developmental research project support will result in the generation of data that will serve as the basis for 
additional HBCs SPORE-sponsored projects or support through other external peer-reviewed mechanisms. 
The HBCs SPORE leadership will work with the investigators to help secure independent R01-level funding. 
One-page outlines of three potential research projects are included to demonstrate the depth and breadth of 
ongoing research that can be eligible for funding through the HBCs SPORE Developmental Research 
Program.

## Key facts

- **NIH application ID:** 10468833
- **Project number:** 5P50CA210964-05
- **Recipient organization:** MAYO CLINIC ROCHESTER
- **Principal Investigator:** MARK A. MC NIVEN
- **Activity code:** P50 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $57,323
- **Award type:** 5
- **Project period:** 2018-09-10 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10468833

## Citation

> US National Institutes of Health, RePORTER application 10468833, Developmental Research Program (5P50CA210964-05). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10468833. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*